On The Pen: The Weekly Dose Podcast
1) Wegovy Pens Recalled & Wegovy Pill Launch
This episode breaks down a pivotal week in GLP-1 obesity medicine, from early trial headlines that overstated results to the launch of the first FDA-approved Wegovy pill for obesity. We also examine m...Show More
2) Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!
The first ever oral option for GLP-1 medications for obesity has been approved and will hit the market in January. Dave covers everything patients need to know in this week's podcast!
3) GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
Don’t miss this live conversation with Sabina from GLPwinner.com as she joins us to discuss the next legal battlefield for compounds: states. We also discuss how the federal legislation is likely a me...Show More
GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
59:05 | Dec 19th, 2025
4) Compounded Retatrutide? What the Judge Said
This episode delivers a deep, unfiltered breakdown of the latest Retatrutide data—showing weight-loss results that approach and even rival bariatric surgery—while exposing the growing battle over acce...Show More
5) Retatrutide Weight Loss: How Much At Each Dose
In this livestream, Dave breaks down new phase 3 retatrutide data, carefully contrasting idealized trial “efficacy estimate” numbers with more realistic “treatment regimen” outcomes, and explores what...Show More
6) Mounjaro vs. New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight
This week’s episode dives into one of the most exciting moments we’ve seen yet in obesity medicine. We break down brand-new data on Wave Life Sciences’ single-injection therapy—showing visceral fat lo...Show More
7) GLP-1: New Metrics, New Molecules, New Prices
This week’s On The Pen podcast unpacked major developments in obesity and metabolic health. New data from Harvard and Mass General suggest that nearly 70% of U.S. adults may qualify as having obesity ...Show More
8) Novo Nordisk Amycretin Shocker + Semaglutide Flopper
Dave opens the episode with gratitude during a difficult week, sharing how the OTP community’s support has helped him stay grounded after losing his 60,000-follower TikTok account overnight. He then b...Show More
9) Wegovy GLP-1 Price Novo Blinks First
10) GLP-1 State of the Union
How much will GLP-1 meds be under Trumps new plan? On this week's podcast, Dave discusses the future of obesity medicine and the current state of branded and compounded GLP-1 meds.